Adamas to Present at Upcoming SVB Leerink CNS Forum

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc.,  (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present “What’s Happening in Parkinson’s Disease & the GOCOVRI Opportunity” at the SVB Leerink CNS Forum on Tuesday, June 29th at 1:10 pm Eastern Time.

The presentation will be broadcast live from the investor relations section of the Adamas website at Replays of the event will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit

Source: Adamas Pharmaceuticals, Inc.


Sarah Mathieson
Vice President, Corporate Communications

Peter Vozzo
Managing Director


Source: Adamas Pharmaceuticals, Inc.

Back to news